CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX), a specialty pharmaceutical company, is focused on the development, licensing and commercialization of pharmaceutical products through the leveraging of their validated drug delivery technology. The company has U.S. and international patents as well as other proprietary rights to technologies that encourage the absorption of drugs. For further information, visit the Company’s web site at www.cpexpharm.com.
- 16 years ago
QualityStocks
CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Aligns Strategy to Drive Long-Term Growth
Massimo Group (NASDAQ: MAMO), a manufacturer of powersports vehicles, is reinforcing its market position through…
-
QualityStocksNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Unveils GibberAds(TM): AI-Powered Platform Redefines Personalized Marketing
Thumzup (NASDAQ: TZUP) is shaking up the multibillion-dollar marketing industry with the launch of its patent-pending…
-
Zacks Initiates Coverage on SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2)
Despite policy uncertainty, demand for scalable solar and storage solutions in North America remains strong,…